Ruxolitinib is used to treat chronic myeloproliferative disorders that have _____ mutations including myelofibrosis and polycythemia vera
_____ approved for the treatment of thrombocytopenia with chronic liver disease.
Patients with sickle cell anemia should not receive pegylated filgrastim as it can trigger a _____.
Hematological complications of Trimethoprim (TMP) use include _____ (granulocytopenia, leukopenia) and megaloblastic anemia
Immune thrombocytopenia can be treated with the TPO receptor agonists _____ and romiplostim
_____ is an oral HIF prolyl hydroxylase inhibitor, used to treat anemia in CKD.
_____ is given to treat thrombocytopenia secondary to anti-cancer therapy.
Hint: IL-11 analog
_____ is considered superior to all other parenteral iron supplementation especially for postpartum IDA.
Treatment of hemophilia A involves _____ plus recombinant factor VIII
_____ is a competitive antagonist of PAR-1
Study 10 flashcards on Hematopoietic Growth Factors for NEET-PG Pharmacology. These active recall cards cover the key concepts, clinical associations, and high-yield facts from this chapter of Drugs Affecting Blood and Blood Formation. Each card is designed to test your understanding rather than just recognition, building stronger and more durable memories for exam day.
For personalised spaced repetition scheduling and unlimited flashcards, download the Oncourse app.
Get full access to all flashcards, spaced repetition, and progress tracking.
Scan to download app